Global Impact of COVID-19 on Pulmonology Special Units

NCT04554251 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-09-18

No results posted yet for this study

Summary

The COVID-19 pandemic is having a profound impact on the world. As of May 18, 2020, there were 4,889,287 confirmed cases and 322,683 deaths globally. The healthcare system is wrestling with a virus that threatens to overwhelm hospital capacity, while simultaneously confronting an unprecedented reduction in elective and non-essential care.

A survey by the American Cancer Society showed that 50% of cancer patients and survivors reported some impact to their healthcare due to the COVID-19 epidemic.

A recent survey was conducted by Forbes et al to evaluate the changes in GI and endoscopy practices in North America.

However, the impact of this epidemic on Pulmonology units ( bronchoscopy, thoracoscopy, ultrsonography and sleep lab) globally has not been studied.

Conditions

  • Covid19
  • Global Impact
  • Pulmonology

Interventions

OTHER

Survey

invited questionnaire

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Aliae Mohamed-Hussein · Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2020-12-01
Completion
2020-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04554251 on ClinicalTrials.gov